EA200800070A1 - Производные 2-(1h-индолилсульфанил)ариламина - Google Patents

Производные 2-(1h-индолилсульфанил)ариламина

Info

Publication number
EA200800070A1
EA200800070A1 EA200800070A EA200800070A EA200800070A1 EA 200800070 A1 EA200800070 A1 EA 200800070A1 EA 200800070 A EA200800070 A EA 200800070A EA 200800070 A EA200800070 A EA 200800070A EA 200800070 A1 EA200800070 A1 EA 200800070A1
Authority
EA
Eurasian Patent Office
Prior art keywords
indolylsulfanil
arylamine
derivatives
compounds
relates
Prior art date
Application number
EA200800070A
Other languages
English (en)
Russian (ru)
Inventor
Ян Келер
Карстен Юль
Мортен Банг Нергор
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200800070A1 publication Critical patent/EA200800070A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200800070A 2005-06-17 2006-06-14 Производные 2-(1h-индолилсульфанил)ариламина EA200800070A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69200905P 2005-06-17 2005-06-17
PCT/IB2006/002785 WO2006134499A2 (en) 2005-06-17 2006-06-14 2-(1h-indolylsulfanyl)-aryl amine derivatives

Publications (1)

Publication Number Publication Date
EA200800070A1 true EA200800070A1 (ru) 2008-04-28

Family

ID=37532681

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800070A EA200800070A1 (ru) 2005-06-17 2006-06-14 Производные 2-(1h-индолилсульфанил)ариламина

Country Status (15)

Country Link
EP (1) EP1893575B1 (enExample)
JP (1) JP5144507B2 (enExample)
KR (1) KR20080027462A (enExample)
CN (1) CN101238101A (enExample)
AR (1) AR054394A1 (enExample)
AU (1) AU2006257288A1 (enExample)
BR (1) BRPI0611748A2 (enExample)
CA (1) CA2611566C (enExample)
EA (1) EA200800070A1 (enExample)
ES (1) ES2616095T3 (enExample)
IL (1) IL188064A0 (enExample)
MX (1) MX2007014954A (enExample)
NO (1) NO20080265L (enExample)
WO (1) WO2006134499A2 (enExample)
ZA (1) ZA200710885B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100286226A1 (en) * 2007-09-24 2010-11-11 H. Lundbeck A/S Combination therapy related to serotonin dual action compounds
TW200938189A (en) * 2008-03-13 2009-09-16 Lundbeck & Co As H [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
US9000025B2 (en) 2010-08-20 2015-04-07 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
ES2687481T3 (es) * 2013-03-15 2018-10-25 Chromocell Corporation Moduladores del canal de sodio para el tratamiento del dolor
EP3046909A4 (en) 2013-09-17 2017-03-29 Pharmakea, Inc. Heterocyclic vinyl autotaxin inhibitor compounds
US9714240B2 (en) 2013-09-17 2017-07-25 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
JP2016531874A (ja) 2013-09-26 2016-10-13 ファーマケア,インク. オートタキシン阻害剤化合物
CA2930737C (en) 2013-11-22 2023-02-21 Pharmakea, Inc. Autotaxin inhibitor compounds
SG10201911204WA (en) 2015-05-27 2020-02-27 Pharmakea Inc Autotaxin inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117129A (en) * 1976-10-22 1978-09-26 Warner-Lambert Company Indolobenzoxazepines as cns depressants
ES2128281T1 (es) * 1995-11-06 1999-05-16 Gist Brocades Bv Proceso de desesterificacion.
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
TW200400177A (en) * 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
JP4090491B2 (ja) * 2003-12-23 2008-05-28 ハー・ルンドベック・アクチエゼルスカベット 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto

Also Published As

Publication number Publication date
MX2007014954A (es) 2008-02-15
EP1893575A2 (en) 2008-03-05
WO2006134499A2 (en) 2006-12-21
JP5144507B2 (ja) 2013-02-13
ZA200710885B (en) 2009-03-25
BRPI0611748A2 (pt) 2016-11-22
AR054394A1 (es) 2007-06-20
NO20080265L (no) 2008-01-15
JP2008546679A (ja) 2008-12-25
ES2616095T3 (es) 2017-06-09
EP1893575B1 (en) 2017-01-11
IL188064A0 (en) 2008-03-20
CN101238101A (zh) 2008-08-06
AU2006257288A1 (en) 2006-12-21
KR20080027462A (ko) 2008-03-27
WO2006134499A3 (en) 2007-04-12
CA2611566A1 (en) 2006-12-21
CA2611566C (en) 2011-08-16

Similar Documents

Publication Publication Date Title
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
ECSP10010722A (es) Compuestos orgánicos
EA201001124A1 (ru) Производные хинолина и их применение в качестве фунгицидов
EA201790678A1 (ru) Бициклические гетероарильные соединения
DK1761520T3 (da) Kinaseinhibitorer
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
NO20071127L (no) Triazoloftalaziner
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
ATE483000T1 (de) Naphtalin-amidin-imide
EA200601568A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
EA200801199A1 (ru) Ингибиторы киназы
EA201000069A1 (ru) Новые гербициды
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4
DOP2005000010A (es) Inhibidores de quinasa
EA201270630A1 (ru) Гетероциклические сетр ингибиторы
NO20082185L (no) Heterocykliske CETP-inhibitorer
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии